Wernicke et al. examined ovarian cancer samples from multiple sites in 10 patients and reported that the percentage of PSMA positive vessels was either similar or higher in metastatic foci as compared to the primary ovarian tumor. This evidence concerns the gene FOLH1 and ovarian cancer.